United States · FDA National Drug Code directory
Plaquenil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59212-562_1138fd4e-dfba-4c96-a5ec-60f8bc1ba746
- Product NDC
- 59212-562
- Form
- TABLET
- Composition / generic term
- Hydroxychloroquine Sulfate
- Labeler
- Advanz Pharma (US) Corp.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130628
- Source listing expiry
- 20271231
Source-listed ingredients
- HYDROXYCHLOROQUINE SULFATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (59212-562-10) · 59212-562-10
- 100 TABLET in 1 BOTTLE (59212-562-11) · 59212-562-11
- 60 TABLET in 1 BOTTLE (59212-562-60) · 59212-562-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →